Video game reads muscle signals to study movement in cerebral palsy and hemiparesis

NCT ID NCT07838688

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 24, 2026 · Last updated Sep 25, 2026 · Updated 1 time

Summary

Researchers at Rennes University Hospital are studying how muscles work during a rehabilitation video game controlled by surface electromyography, which detects muscle activity through sensors on the skin. The study includes children with cerebral palsy, adults with hemiparesis after a stroke, and healthy volunteers. Participants play a single 30-minute game session in different modes, such as one-player or two-player, and researchers measure muscle activation and the number of contractions. The study also asks how enjoyable, motivating, and usable the game feels to adults with hemiparesis.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a rehabilitation video game controlled by surface electromyography, which reads muscle signals through sensors on the skin
What this could lead to
If the game produces useful muscle activity and players enjoy it, it could inform future rehabilitation tools for people with cerebral palsy or hemiparesis.
What could go wrong
This is a small, single-session pilot study with 50 participants. It measures muscle signals during one game session, so it cannot show whether the game improves strength, movement, or daily function over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2027

An estimate. Start dates often move.

Expected to finish

Jan 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

7 to 85 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for children with cerebral palsy: * Participants with cerebral palsy who are able to walk, GMFCS stages I through III, hemiplegic, diplegic, or quadriplegic * Aged 7 to 17 years * With palpable contractions of the target muscles (triceps surae and tibialis anterior) (≥ 1 on the Medical Research Council \[MRC\] scale) * Having received verbal and written information about the protocol, having agreed to participate in this study, and having signed a consent form if the participant is 15 years of age or older * Signed consent for participation from the participant's legal guardians * Enrolled, either personally or through their parents, in a social security program Inclusion Criteria for adults with hemiparesis * Stroke in the subacute or chronic phase * Aged 18 to 85 years * With palpable contractions of the target muscles (triceps surae and tibialis anterior) (≥ 1 on the Medical Research Council \[MRC\] scale) * Having received verbal and written information about the protocol and having signed a consent form to participate in this study * Enrolled in a social security program Inclusion Criteria for Healthy subjects matched for age to the group of participants with hemiparesis * Aged 18 to 85 * No neurological disorders * Who received verbal and written information about the protocol and signed a consent form to participate in this study. Exclusion Criteria: * Surgery on the lower extremities within the past 6 months * A botulinum toxin injection into the triceps surae and/or the tibialis anterior within the past 3 months * Pain during dorsiflexion or plantarflexion of the ankle joint * Cognitive impairments limiting participation * A person referred to in Articles L1121-5, L1121-6, L2121-8, L1121-9 of the Public Health Code * Participating in another therapeutic or drug intervention study that could affect this study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebral palsy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU de RENNES

    Rennes, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.